PDF herunterladen
CC BY-NC-ND 4.0 · South Asian J Cancer 2024; 13(02): 150-156
DOI: 10.1055/s-0042-1758570
Original Article
Brain Tumour

Primary Intramedullary Spinal High-Grade Glioma: A Case Series with Review of Literature

Aashita Aashita
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Rajiv Sharma
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Vikas Yadav
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Muthu Manikandan
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Ankit Dhameliya
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Hemendra Mishra
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
,
Pragyat Thakur
2   Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur (Affiliated to HBNI, Mumbai), Maharashtra, India
,
Abhidha Malik
1   Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Zoom Image
Aashita

Background Primary intramedullary high-grade glioma (HGG) and glioblastoma of spinal cord are uncommon tumors of central nervous system. Treatment recommendations are based on current guidelines of intracranial HGG and glioblastoma multiforme (GBM).

Methods We retrospectively analyzed records of 9,686 patients who reported to our center over past 7 years. Only three cases of primary intramedullary HGG of spinal cord were found.

Results In this article, we have reported three cases of primary intramedullary HGG of spinal cord. A comparison of intracranial and intramedullary spinal HGG and review of literature is presented.

Conclusion Despite aggressive treatment using surgery, radiation, and chemotherapy, the survival rates are dismal. Emerging evidence has shown difference in biological behavior of intracranial and spinal HGG. Genetic studies to understand the biology and prospective studies are needed.

Keywords

glioblastoma - spinal glioblastoma - spinal astrocytoma - intramedullary glioma - high-grade glioma

Ethical Approval

Taken as applicable in our center. The patients consented for treatment and collection of data.


Consent for Publication

Written informed consent to publish was obtained from individual patients.


Authors' Contributions

A was involved in conceptualization, writing—original draft and editing; RS contributed to conceptualization, editing, and review; VY contributed to editing and supervision; MM and AD edited and reviewed the manuscript; HK, PT, and AM supervised and reviewed the study.




Publikationsverlauf

Artikel online veröffentlicht:
02. Dezember 2022

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Chamberlain MC, Tredway TL. Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep 2011; 11 (03) 320-328
    CrossrefPubMedSuche in Google Scholar
  • 2 Abd-El-Barr MM, Huang KT, Moses ZB, Iorgulescu JB, Chi JH. Recent advances in intradural spinal tumors. Neuro-oncol 2018; 20 (06) 729-742
    CrossrefPubMedSuche in Google Scholar
  • 3 Alvi MA, Ida CM, Paolini MA. et al. Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation. Mod Pathol 2019; 32 (09) 1236-1243
    CrossrefPubMedSuche in Google Scholar
  • 4 Liu J, Zheng M, Yang W, Lo SL, Huang J. Impact of surgery and radiation therapy on spinal high-grade gliomas: a population-based study. J Neurooncol 2018; 139 (03) 609-616
    CrossrefPubMedSuche in Google Scholar
  • 5 Kandemirli SG, Reddy A, Hitchon P, Saini J, Bathla G. Intramedullary tumours and tumour mimics. Clin Radiol 2020; 75 (11) 876.e17-876.e32
    CrossrefPubMedSuche in Google Scholar
  • 6 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131 (06) 803-820
    CrossrefPubMedSuche in Google Scholar
  • 7 Nagarajan A, Ravichandar R. Glioblastoma multiforme of spinal cord - case series in a tertiary cancer centre. J Clin Transl Res 2021; 7 (06) 792-796
    PubMedSuche in Google Scholar
  • 8 Nagaishi M, Nobusawa S, Yokoo H. et al. Genetic mutations in high grade gliomas of the adult spinal cord. Brain Tumor Pathol 2016; 33 (04) 267-269
    CrossrefPubMedSuche in Google Scholar
  • 9 Jung JS, Choi YS, Ahn SS, Yi S, Kim SH, Lee SK. Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging. Neuroradiology 2019; 61 (03) 313-322
    CrossrefPubMedSuche in Google Scholar
  • 10 Choi SH, Yoon HI, Yi S. et al. Treatment outcomes of radiotherapy for primary spinal cord glioma. Strahlenther Onkol 2019; 195 (02) 164-174
    CrossrefPubMedSuche in Google Scholar
  • 11 Kim WH, Yoon SH, Kim CY. et al. Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. J Neurooncol 2011; 101 (02) 247-254
    CrossrefPubMedSuche in Google Scholar
  • 12 Yi S, Choi S, Shin DA. et al. Impact of H3.3 K27M mutation on prognosis and survival of grade IV spinal cord glioma on the basis of new 2016 World Health Organization classification of the central nervous system. Neurosurgery 2019; 84 (05) 1072-1081
    CrossrefPubMedSuche in Google Scholar
  • 13 Wang YZ, Zhang YW, Liu WH. et al. Spinal cord diffuse midline gliomas with H3 K27m-Mutant. Neurosurgery 2021; 89 (02) 300-307
    CrossrefPubMedSuche in Google Scholar
  • 14 Xie T, Feng Y, Song J, Yao G. Anterior dorsal root entry zone approach in the treatment of spinal intramedullary glioma. World Neurosurg 2021; 153: 139
    CrossrefPubMedSuche in Google Scholar
  • 15 Kotecha R, Mehta MP, Chang EL. et al. Updates in the management of intradural spinal cord tumors: a radiation oncology focus. Neuro-oncol 2019; 21 (06) 707-718
    CrossrefPubMedSuche in Google Scholar
  • 16 Sahgal A, Chang JH, Ma L. et al. Spinal cord dose tolerance to stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2021; 110 (01) 124-136
    CrossrefPubMedSuche in Google Scholar
  • 17 Indelicato DJ, Rotondo RL, Uezono H. et al. Outcomes following proton therapy for pediatric low-grade glioma. Int J Radiat Oncol Biol Phys 2019; 104 (01) 149-156
    CrossrefPubMedSuche in Google Scholar
  • 18 Kaley TJ, Mondesire-Crump I, Gavrilovic IT. Temozolomide or bevacizumab for spinal cord high-grade gliomas. J Neurooncol 2012; 109 (02) 385-389
    CrossrefPubMedSuche in Google Scholar
  • 19 Majzner RG, Ramakrishna S, Yeom KW. et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 2022; 603 (7903): 934-941
    CrossrefPubMedSuche in Google Scholar
  • 20 Wolff B, Ng A, Roth D. et al. Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. J Neurooncol 2012; 107 (01) 139-146
    CrossrefPubMedSuche in Google Scholar
  • 21 Miller KD, Ostrom QT, Kruchko C. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin 2021; 71 (05) 381-406
    CrossrefPubMedSuche in Google Scholar
  • 22 Grimm SA, Chamberlain MC. Anaplastic astrocytoma. CNS Oncol 2016; 5 (03) 145-157
    CrossrefPubMedSuche in Google Scholar
  • 23 Takamiya S, Hatanaka KC, Ishi Y, Seki T, Yamaguchi S. Spinal cord anaplastic astrocytoma with BRAF V600E mutation: a case report and review of literature. Neuropathology 2020; 40 (03) 275-279
    CrossrefPubMedSuche in Google Scholar
  • 24 Yao J, Wang L, Ge H, Yin H, Piao Y. Diffuse midline glioma with H3 K27M mutation of the spinal cord: a series of 33 cases. Neuropathology 2021; 41 (03) 183-190
    CrossrefPubMedSuche in Google Scholar